Loading...
OTCM
CHME
Market cap2kUSD
Apr 04, Last price  
0.00USD
Name

China Medicine Corp

Chart & Performance

D1W1MN
OTCM:CHME chart
No data to show
P/E
0.00
P/S
0.00
EPS
0.06
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
%
Revenues
65m
+20.70%
10,400,325023,991,95042,105,38753,647,80664,751,018
Net income
2m
-81.18%
2,939,660-32,5004,787,8746,875,3699,125,6161,717,677
CFO
17m
+302.92%
2,546,274-32,500-2,218,208-2,310,1134,209,08416,959,384

Profile

China Medicine Corporation produces and distributes prescription and over the counter drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. The company offers various products for applications, including oncology, high blood pressure, and removal of toxins from food and animal feeds. It provides products that treat stagnation of the heart blood, obstruction of qi in the chest, cardiodynia, headache, and dysmenorrhea; upper respiratory tract infection, acute faucitis, acute tonsillitis, acute gastroenteritis, etc.; acute and chronic hepatitis, deferment hepatitis, cholecystitis, etc.; irregular menstruation, dysmenorrhea, and amenorrhea; anemia and deficiency of vital energy; palpitation, dizziness, and fatigue; and cerebral arteriosclerosis and ischemic stroke. The company distributes its products through a sales network in China. The company was formerly known as Lounsberry Holdings III, Inc. and changed its name to China Medicine Corporation in May 2006. China Medicine Corporation was founded in 2005 and is based in Guangzhou, China.
IPO date
Jun 23, 2005
Employees
Domiciled in
CN
Incorporated in
US

Valuation

No data to show